Capussotti L, Massucco P, Muratore A, Amisano M, Bima C, Zorzi D
Unit of Surgical Oncology, Institute for Research and Cure of Cancer, 10060, Candiolo, Italy.
Surg Endosc. 2004 Jul;18(7):1130-5. doi: 10.1007/s00464-003-9152-3. Epub 2004 May 27.
Several studies reporting preliminary long-term survival data after laparoscopic resections for colonic adenocarcinoma did not show any detrimental effect in comparison with historic studies of laparotomies. A previous randomized study has reported an unforeseen better long-term survival for node-positive patients treated by laparoscopic colectomy.
A single-institution prospective nonrandomized trial compared short- and long-term results of laparoscopic and open curative resection for adenocarcinoma of the left colon or rectum in 255 consecutive patients from January 1996 to December 2000.
In this study, 34 left hemicolectomy, 202 anterior resections, and 19 abdominoperineal resections were performed. A total of 74 patients underwent a laparoscopic resection (LR), and 181, an open resection (OR). The tumor site was the descending colon in 32 cases, the sigmoid colon in 98 cases, and the rectum in 125 cases, including 87 mid-low rectal cancers. Ten LR procedures (13.5%) were converted to open surgery. The hospital mortality was 0.08%, and in hospital morbidity was 16.2% for LR and 13.3% for OR (p = 0.56). The median postoperative stay was 1 day shorter for LR (9 days) than for OR (10 days) (p = 0.09). The mean number of lymph nodes retrieved were 13.8 +/- 5.7 for OR and 12.7 +/- 5; for LR (p = 0.23). Age exceeding 70 years, T stage, N stage, grading, mid-low rectal site, and laparoscopy were found by multivariate analysis to be significant prognostic factors for disease-free and cancer-related survival. When patients were stratified by stage, a trend toward a better disease-free and cancer-related survival was identified in stage III patients undergoing LR.
Laparoscopic colonic resection is a safe procedure in terms of postoperative outcome and long-term survival. Multivariate analysis showed that laparoscopy is a positive prognostic factor for disease-free and cancer-related survival. The current data agrees with the data for the only randomized study reported so far. Both suggest a better outcome for node-positive patients treated by laparoscopy.
几项报告腹腔镜结肠腺癌切除术后初步长期生存数据的研究与既往剖腹手术的研究相比,未显示出任何有害影响。此前一项随机研究报告称,接受腹腔镜结肠切除术治疗的淋巴结阳性患者的长期生存率出人意料地更高。
一项单机构前瞻性非随机试验比较了1996年1月至2000年12月期间255例连续的左半结肠癌或直肠癌患者接受腹腔镜和开放根治性切除术的短期和长期结果。
在本研究中,进行了34例左半结肠切除术、202例前切除术和19例腹会阴联合切除术。共有74例患者接受了腹腔镜切除术(LR),181例接受了开放切除术(OR)。肿瘤部位为降结肠32例,乙状结肠98例,直肠125例,其中包括87例中低位直肠癌。10例LR手术(13.5%)转为开放手术。医院死亡率为0.08%,LR的住院发病率为16.2%,OR为13.3%(p = 0.56)。LR术后中位住院时间(9天)比OR(10天)短1天(p = 0.09)。OR组平均获取淋巴结数为13.8±5.7个,LR组为12.7±5个(p = 0.23)。多因素分析发现,年龄超过70岁、T分期、N分期、分级、中低位直肠部位和腹腔镜检查是无病生存和癌症相关生存的重要预后因素。当患者按分期分层时,III期接受LR的患者在无病生存和癌症相关生存方面有更好的趋势。
就术后结果和长期生存而言,腹腔镜结肠切除术是一种安全的手术。多因素分析表明,腹腔镜检查是无病生存和癌症相关生存的积极预后因素。目前的数据与迄今为止报告的唯一一项随机研究的数据一致。两者均表明,腹腔镜治疗的淋巴结阳性患者预后更好。